Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronika Brixner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 12, 2024
Impact of Shelf-Life Extension on Platelet Availability: Results from an Inventory Management Modeling StudyVeronika Brixner, Marcia Cardoso, Erik Spaepen, et al.
Transfusion|December 29, 2017
Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentratesSinyoung Kim, Wiebke Handke, Ute Gravemann, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 17, 2003
Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatusChristian Drosten, Thomas Nippraschk, Christoph Manegold, et al.
Transfusion|March 27, 2004
NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissionsMichael Schmidt, Veronika Brixner, Brigitte Ruster, et al.
Cytotherapy|November 13, 2016
Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent miceJohannes Leibacher, Katrin Dauber, Sabrina Ehser, et al.
Transfusion|July 22, 2020
Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cellsChristof Geisen, Anne North, Lisa Becker, et al.
Transfusion|May 10, 2008
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virusMichael K Hourfar, Christine Jork, Volkmar Schottstedt, et al.
Transfusion|March 3, 2018
Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgeryVeronika Brixner, Arndt-Holger Kiessling, Katharina Madlener, et al.
Haematologica|February 4, 2021
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trialVeronika Brixner, Gesine Bug, Petra Pohler, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 12, 2024
Impact of Shelf-Life Extension on Platelet Availability: Results from an Inventory Management Modeling StudyVeronika Brixner, Marcia Cardoso, Erik Spaepen, et al.
Transfusion|December 29, 2017
Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentratesSinyoung Kim, Wiebke Handke, Ute Gravemann, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 17, 2003
Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatusChristian Drosten, Thomas Nippraschk, Christoph Manegold, et al.
Transfusion|March 27, 2004
NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissionsMichael Schmidt, Veronika Brixner, Brigitte Ruster, et al.
Cytotherapy|November 13, 2016
Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent miceJohannes Leibacher, Katrin Dauber, Sabrina Ehser, et al.
Transfusion|July 22, 2020
Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cellsChristof Geisen, Anne North, Lisa Becker, et al.
Transfusion|May 10, 2008
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virusMichael K Hourfar, Christine Jork, Volkmar Schottstedt, et al.
Transfusion|March 3, 2018
Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgeryVeronika Brixner, Arndt-Holger Kiessling, Katharina Madlener, et al.
Haematologica|February 4, 2021
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trialVeronika Brixner, Gesine Bug, Petra Pohler, et al.
Pageof 1